All Stories

  1. Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings
  2. False-positive EGFR Mutation-specific Immunohistochemistry in HER2-positive Breast Cancers
  3. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma
  4. Differences in the Pathological Diagnosis and Repeat Craniotomy Rates in Cerebral Tumors Undergoing Biopsy or Resection in an Urban Versus Regional Center
  5. Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
  6. BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry
  7. Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions
  8. Abstract 3875: Merkel cell carcinomas in Australia have distinct mutation profiles reflecting viral etiology and UV-related DNA damage
  9. Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
  10. Risk of malignancy for each Bethesda class in pediatric thyroid nodules
  11. Abstract PR06: The ampullary adenocarcinoma, its molecular characterization and differentiation from the pancreatic ductal adenocarcinoma, duodenal adenocarcinoma, and cholangiocarcinoma
  12. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation
  13. Loss of expression of BAP1 predicts longer survival in mesothelioma
  14. EquivocalALKfluorescencein-situhybridization (FISH) cases may benefit from ancillaryALKFISH probe testing
  15. Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma
  16. An Unusual Cause of Torrential Lower Gastrointestinal Hemorrhage
  17. A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
  18. Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): Common hepatic arterial stump pressure should determine the need for arterial reconstruction
  19. Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report
  20. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas
  21. The genomic landscape of phaeochromocytoma
  22. ALK and ROS1 Overexpression is Very Rare in Colorectal Adenocarcinoma
  23. Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases
  24. Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
  25. 18. IMP3 expression in triple-negative breast cancer
  26. 15. Analysis of primary renal and urothelial neoplasia at royal north shore hospital from 1998–2013
  27. 19. Mitochondrial complex II insufficiency occurs rarely in breast carcinoma
  28. 21. Audit of primary brain tumours at royal north shore hospital from 2007 to 2011
  29. Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases
  30. Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
  31. Skin rash, a kidney mass and a family mystery dating back to World War II
  32. Tuberous Sclerosis–associated Renal Cell Carcinoma
  33. EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer
  34. A Further Investigation of Combined Mismatch Repair and BRAFV600E Mutation Specific Immunohistochemistry as a Predictor of Overall Survival in Colorectal Carcinoma
  35. Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency
  36. Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer
  37. The Impact of Maternal Cigarette Smoke Exposure in a Rodent Model on Renal Development in the Offspring
  38. A histologic evaluation of the laparoscopic adjustable gastric band capsule by tissue sampling during sleeve gastrectomy performed at different time points after band removal
  39. The incidence of mismatch repair gene defects in colorectal liver metastases
  40. Bethesda III Thyroid Nodules: The Role of Ultrasound in Clinical Decision Making
  41. Parasitic thyroid nodules: cancer or not?
  42. Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility
  43. Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
  44. Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer
  45. Understanding the Genetic Basis of Parathyroid Carcinoma
  46. 19. Frozen section improves the complete excision rates for whipple’s resection
  47. BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas
  48. 10. Clinicopathological features of HER2 amplified pancreatic cancer
  49. 21. Data mining of non-synoptic colorectal cancer pathology reports at the royal north shore hospital
  50. 9. Cyclin-Dependent kinase inhibitor as a potential novel therapeutic agent for pancreatic cancer
  51. Returning individual research results for genome sequences of pancreatic cancer
  52. Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma
  53. Mutations inKCNJ5determines presentation and likelihood of cure in primary hyperaldosteronism
  54. Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation
  55. MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
  56. BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer
  57. Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas
  58. Abstract A10: A mutagenesis screen identifies tumor suppressors and kinases as potential driver genes of ovarian cancer
  59. Abstract A29: Loss of histone H2B monoubiquitination in ovarian cancer – new therapeutic targeting opportunities based on chromatin relaxation
  60. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma
  61. BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome
  62. Of mice and men… and models of metastatic colorectal carcinoma
  63. FamilialSDHAMutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma
  64. Abstract 330: Utilization of Sleeping Beauty mutagenesis for the identification of potential driver genes of ovarian cancer.
  65. Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors
  66. Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CT
  67. Level VII is an Important Component of Central Neck Dissection for Papillary Thyroid Cancer
  68. 13. Intestinal spirochetosis: a retrospective review
  69. von Hippel-Lindau Syndrome
  70. 14. Trends in acute cellular rejection in renal transplant biopsies
  71. Evaluation of anaplastic lymphoma kinase (ALK) rearrangements using ALK/EML4 tricheck fluorescence in situ hybridisation (FISH) in non-small cell lung cancers (NSCLC)
  72. 12. Diagnostic trends in malignant mesothelioma at royal north shore hospital over a 12 year period
  73. 15. Trends of primary diagnoses in renal biopsies
  74. Inferior vena cava epithelioid hemangioendothelioma
  75. Utility of cardiac magnetic resonance in assessing right-sided heart failure in sarcoidosis
  76. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours
  77. Nodal metastasis microRNA expression correlates with the primary tumour in MTC
  78. Grafts for Mesenterico-Portal Vein Resections Can Be Avoided during Pancreatoduodenectomy
  79. qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
  80. Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma
  81. Remote frozen section examination of breast sentinel lymph nodes by telepathology
  82. Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease?
  83. MGMT expression and pituitary tumours: relationship to tumour biology
  84. Abstract B64: A molecular preoperative prognostic nomogram for resectable pancreatic cancer.
  85. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer
  86. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
  87. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression
  88. Abstract 2167: The tumor suppressor CDC73/parafibromin is required for the maintenance of histone 2B monoubiquitination both in vitro and in vivo
  89. Classification of Parathyroid Cancer
  90. Mucoepidermoid Carcinoma of the Thyroid: A Report of Three Cases and Postulated Histogenesis
  91. RON is not a prognostic marker for resectable pancreatic cancer
  92. Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy
  93. Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population
  94. Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology
  95. Benign mesothelial cells as confounders when cytokeratin immunohistochemistry is used in sentinel lymph nodes
  96. “Pediatric-Type” Gastrointestinal Stromal Tumors Are SDHB Negative (“Type 2”) GISTs
  97. One hundred and seventy-eight consecutive pancreatoduodenectomies without mortality: role of the multidisciplinary approach
  98. Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4
  99. Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas
  100. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma: authors’ reply
  101. Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases
  102. A Systematic Review of the Interobserver Variability for Histology in the Differentiation between Squamous and Nonsquamous Non-small Cell Lung Cancer
  103. BRAFV600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer
  104. Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery
  105. Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment
  106. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma
  107. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
  108. Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
  109. 4. A comparison of synpoptic and free-text reporting in oesophageal carcinoma
  110. 5. Audit of sentinel node frozen sections at royal north shore hospital
  111. 6. A comparison of podoplanin and calretinin as imunohistochemical markers for sarcomatoid mesothelioma
  112. 7. A case report of thymic squamous cell carcinoma
  113. 16. Primary choriocarcinoma of the colon – a case report
  114. The Glucocorticoid Receptor Is Overexpressed in Malignant Adrenocortical Tumors
  115. The Glucocorticoid Receptor Is Overexpressed in Malignant Adrenocortical Tumors
  116. Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
  117. Intra-Abdominal Insular Thyroid Carcinoma Metastasis
  118. Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
  119. Hyperparathyroidism After Irradiation for Childhood Malignancy
  120. Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
  121. Synoptic reporting improves histopathological assessment of pancreatic resection specimens
  122. Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma
  123. PTH Mutation with Primary Hyperparathyroidism and Undetectable Intact PTH
  124. Diagnosis of autoimmune pancreatitis with intraductal biliary biopsy and treatment of stricture with serial placement of multiple biliary stents
  125. Sporadic Pancreatic Polypeptide Secreting Tumors (PPomas) of the Pancreas
  126. Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue
  127. Nonfunctioning Parathyroid Cancer Presenting as a Cervical Mass
  128. Wnt Pathway Inhibitors Are Strongly Down-Regulated in Pituitary Tumors
  129. Loss of Heterozygosity of 17p13, With Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors
  130. Molecular diagnosis of primary hyperparathyroidism in familial cancer syndromes
  131. INTUSSUSCEPTION OF THE VERMIFORM APPENDIX DUE TO ENDOMETRIOSIS PRESENTING AS ACUTE APPENDICITIS
  132. High Expression of Plasminogen Activator Inhibitor-2 (PAI-2) is a Predictor of Improved Survival in Patients with Pancreatic Adenocarcinoma
  133. MODIFIED EXTENDED PANCREATODUODENECTOMY: EN BLOC RESECTION OF THE PERIPANCREATIC RETROPERITONEAL TISSUE AND THE HEAD OF PANCREAS
  134. Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias
  135. Elevated serum FGF23 concentrations in plasma cell dyscrasias
  136. Assessment of HER-2 Status in Pancreatic Adenocarcinoma
  137. Bong Lung: Regular Smokers of Cannabis Show Relatively Distinctive Histologic Changes That Predispose to Pneumothorax
  138. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction
  139. Systematic Response to Talc Pleurodesis
  140. Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia
  141. Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas